Examkin

Soru

Zorluk: OrtaEndocrinology and Metabolism

A 41-year-old woman presents to the clinic to evaluate a newly discovered lump in her neck. She noticed it two weeks ago while adjusting a necklace. She reports no pain, dysphagia, or hoarseness but admits to a recent onset of mild anxiety and intermittent palpitations, which she attributes to stress at work. She has no other medical conditions and takes no medications. Vital signs show a heart rate of 9898/min and blood pressure of 122/78122/78 mm Hg. Physical examination reveals a palpable, mobile, 2.52.5-cm nodule in the right thyroid lobe with no cervical lymphadenopathy. A dedicated neck ultrasound confirms a 2.52.5-cm solid, circumscribed nodule in the right thyroid lobe without suspicious sonographic features (e.g., no microcalcifications or irregular margins). Laboratory testing reveals a serum thyroid-stimulating hormone (TSH) level of 0.10.1 μ\mu U/mL (normal: 0.4–4.2 μ\mu U/mL) and a free thyroxine (T4) level of 1.51.5 ng/dL (normal: 0.8–2.7 ng/dL). Which of the following is the most appropriate next step in management?

  1. Radionuclide thyroid scintigraphyCevap
  2. B
    Fine-needle aspiration biopsy of the nodule
  3. C
    Initiation of methimazole therapy
  4. D
    Measurement of serum thyroglobulin concentration
  5. E
    Measurement of thyroid-stimulating immunoglobulins

Cevap

The most appropriate next step in management is to perform a radionuclide thyroid scintigraphy.
The standard diagnostic algorithm for a newly discovered thyroid nodule begins with a clinical evaluation, a thyroid ultrasound, and a serum TSH measurement. The subsequent steps depend entirely on the TSH level. If the TSH is normal or elevated, the next step is typically an ultrasound-guided fine-needle aspiration (FNA) biopsy, assuming the nodule meets size and sonographic criteria. However, if the TSH is subnormal (suppressed), as seen in this patient, the next best step is radionuclide thyroid scintigraphy (typically using Iodine-123 or Technetium-99m). The purpose of the scan is to determine the functional status of the nodule. If the nodule shows increased uptake ('hot' or hyperfunctioning nodule), the risk of malignancy is extremely low, and FNA is deferred. If the nodule shows decreased uptake compared to surrounding tissue ('cold' or nonfunctioning nodule), the risk of malignancy is higher, and FNA is then indicated.

Adım Adım Çözüm

1
Analyze the clinical presentation and physical examination.
The patient has a clinically evident 2.52.5-cm thyroid nodule, confirmed as a solid nodule on ultrasound, along with mild symptoms of hyperthyroidism (anxiety, palpitations, tachycardia).
Establishing the presence of a true nodule dictates the diagnostic pathway.
2
Interpret the laboratory findings.
The TSH is subnormal (0.10.1 μ\mu U/mL), while the free T4 is within normal limits, indicating subclinical hyperthyroidism or a hyperfunctioning nodule (e.g., toxic adenoma).
The initial laboratory test in the evaluation of any thyroid nodule is the TSH level, which determines the subsequent algorithm.
3
Determine the algorithmic next step based on the suppressed TSH.
A radionuclide thyroid scan is required.
When TSH is low, a radionuclide scan is necessary to see if the nodule is 'hot' (hyperfunctioning) or 'cold' (nonfunctioning). Hyperfunctioning nodules are rarely malignant and generally do not require biopsy, whereas nonfunctioning nodules carry a higher malignancy risk and require further evaluation.

Anahtar Kavram

Evaluation algorithm for a solitary thyroid nodule with a suppressed TSH level
Bu soruyu puanla

Konular

Endocrinology and Metabolism

Bu konudan daha fazla soru